Medical Devices France

France Body Composition Analyzers Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

France Body Composition Analyzers Market Industry Trends and Forecast to 2034: Segmented by (Technology, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

France · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $23.3 Mn Placeholder estimate
Estimate 2025 $24.9 Mn 2.4% of the global market
Projected 2034 $46.6 Mn 87% Adds $21.7 Mn over 9 forecast years
CAGR 2025–2034 7.2% Faster than 46% of 173 Medical Devices markets here
Key players 6 +1
  • France is 2.38% of the global market.
  • In Europe, the largest is Germany at $37.9 Mn.
  • Fastest growing: Russia at 7.8% a year.
  • France ranks 4th of 6 by size in Europe.

Market size projection

France

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$21.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Body Composition Analyzers Market market size by year, France
YearMarket sizeChange that yearSince 2025
2024 (estimate) $23.3 Mn — —
2025 (base) $24.9 Mn +$1.7 Mn —
2026 (forecast) $26.7 Mn +$1.8 Mn +7.2%
2027 (forecast) $28.7 Mn +$1.9 Mn +14.9%
2028 (forecast) $30.7 Mn +$2.1 Mn +23.2%
2029 (forecast) $32.9 Mn +$2.2 Mn +32.1%
2030 (forecast) $35.3 Mn +$2.4 Mn +41.6%
2031 (forecast) $37.8 Mn +$2.5 Mn +51.8%
2032 (forecast) $40.6 Mn +$2.7 Mn +62.7%
2033 (forecast) $43.5 Mn +$2.9 Mn +74.4%
2034 (forecast) $46.6 Mn +$3.1 Mn +87%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.05 Bn
  2. North America $486.8 Mn
  3. US $373.8 Mn
  4. APAC $229.4 Mn
  5. Europe $215.0 Mn
  6. China $80.2 Mn
  7. Canada $76.0 Mn
  8. Japan $72.0 Mn
  9. Latin America $45.3 Mn
  10. Middle East $40.5 Mn
  11. Germany $37.9 Mn
  12. Italy $28.6 Mn
  13. UK $26.2 Mn
  14. Brazil $26.3 Mn
  15. France (this report) $24.9 Mn
  16. Ecuador $23.4 Mn
  17. Saudi Arabia $20.5 Mn
  18. India $20.5 Mn
  19. Spain $18.7 Mn
  20. Mexico $17.4 Mn
  21. Africa $13.9 Mn
  22. Australia $13.3 Mn
  23. Russia $11.5 Mn
  24. New Zealand $11.0 Mn
  25. South Africa $5.9 Mn
  26. UAE $5.2 Mn
  27. Egypt $2.6 Mn
  28. Philippines $2.4 Mn
  29. Malaysia $1.7 Mn
  30. Hong Kong $1.6 Mn
  31. Singapore $1.4 Mn
  32. Thailand $1.2 Mn
  33. Kenya $0.8 Mn

Report snapshot

France Body Composition Analyzers Market Analysis at a glance
Market size, 2025$24.9 Mn placeholder estimate
Forecast, 2034$46.6 Mn placeholder estimate
Growth (CAGR), 2025–20347.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, product and end user (see all)
Key playersInBody, Tanita, Omron Healthcare, Withings, Seca and 1 more (see all)
Regulator in FranceANSMSource: ANSM, French medicines agency. Checked 14 Nov 2026.
Active clinical trials1 in FranceSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in France. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The France Body Composition Analyzers Market Analysis Executive Summary

Body composition analyzers measure fat, muscle and water in the body, used in clinics, gyms and homes to track health and weight-loss progress.

Key segments of the body Composition Analyzers market include technology (Bioelectrical Impedance, DEXA and Air Displacement) and product (Professional Analyzers and Smart Scales).

Bar chart: France Body Composition Analyzers market size, 2024–2034, placeholder estimates. $23.3 Mn in 2024, $24.9 Mn in 2025 and $46.6 Mn in 2034, 7.2% CAGR.
France Body Composition Analyzers market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

France Body Composition Analyzers Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the body Composition Analyzers market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the body Composition Analyzers market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the body Composition Analyzers market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Body Composition Analyzers Market in France

The body Composition Analyzers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Body Composition Analyzers Market in France

Body Composition Analyzers in France: rules, payment and research

Medical devices need CE marking under the EU Medical Device Regulation (MDR); ANSM, the French medicines agency, monitors their safety in France.⁠[1] National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover.⁠[2] ClinicalTrials.gov lists 1 study on Body Composition Analyzers that is recruiting, active or about to start in France.⁠[3] Obesity (adults): 11.2% of adults in 2024, the latest WHO figure for France.⁠[4]

[1] ANSM, French medicines agency. Checked 14 Nov 2026.

[2] Assurance Maladie (ameli.fr). Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in France. Retrieved 12 Nov 2026.

[4] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how body Composition Analyzers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in France.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Body Composition Analyzers right now, from free public sources.

Latest research 8 papers since 2021 (worldwide)

  1. Comparisons of core component delivery in cardiac rehabilitation programs by country income classification and decade based on the 2025 Global Audit Update: A survey study. PLoS medicine, 2026
  2. Comparative analysis of body composition results of university students obtained using two bioimpedance analyzers. Journal of electrical bioimpedance, 2025
  3. Evaluating the RESET care program: Advancing towards scalable and effective healthcare solutions for metabolic dysfunction-associated liver disease. World journal of hepatology, 2025
  4. Investigation of Skeletal Muscle Indices Affecting Anaerobic Thresholds after Acute Myocardial Infarction. Physical therapy research, 2024
  5. Metagenomic and metabolomic analysis showing the adverse risk-benefit trade-off of the ketogenic diet. Lipids in health and disease, 2024
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Body Composition Analyzers in context

France compared

  • Obesity (adults): 11.2% of adults (2024). World: 16.2% of adults (2024). 6th highest of the 6 countries we cover in Europe.[1]
  • Health spending per person: 5,327 US$ per person (2024). World: 1,317 US$ per person (2023). 3rd highest of the 6 countries we cover in Europe.[2]
  • Doctors: 3.28 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 6th highest of the 6 countries we cover in Europe.[3]

[1] WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Body Composition Analyzers market in France?
Placeholder estimate: about $24.9 Mn in 2025, rising to about $46.6 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Body Composition Analyzers market in France growing?
Placeholder estimate: about 7.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Body Composition Analyzers market report cover?
The report splits the market by technology (Bioelectrical Impedance, DEXA, Air Displacement, Skinfold Calipers), product (Professional Analyzers, Smart Scales) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Body Composition Analyzers market?
Key players include InBody, Tanita, Omron Healthcare, Withings, Seca and GE Healthcare.
What is driving the Body Composition Analyzers market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the body Composition Analyzers market.
Who regulates Body Composition Analyzers in France?
Medical devices need CE marking under the EU Medical Device Regulation (MDR); ANSM, the French medicines agency, monitors their safety in France. Source: ANSM, French medicines agency. Checked 14 Nov 2026.
How is healthcare paid for in France?
National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover. Source: Assurance Maladie (ameli.fr). Checked 14 Nov 2026.
How many clinical trials on Body Composition Analyzers are running in France?
1 study is recruiting, active or about to start in France, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in France. Retrieved 12 Nov 2026.
What does WHO report for France?
Obesity (adults): 11.2% of adults in 2024, the latest WHO figure. Source: WHO Global Health Observatory, Obesity (adults) (% of adults). Retrieved 15 Nov 2026.
How many people in France are 65 or older?
22.5% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Body Composition Analyzers in France? Our analysts can size it for your plan. Talk to us See the public data Obesity (adults) for every country, free. Open the Public Health Dashboard

From our blog

Sports Nutrition: From Athletes to Everyday UsersAn IOC study found 14.8% of supplements tested contained undeclared steroids. Sports nutrition now sells to… Weight Management Supplements in the GLP-1 Era2.6 billion adults are overweight. GLP-1 medicines are changing weight care, while most supplements lack… Creatine: The Supplement Going MainstreamCreatine is one of the most studied supplements in sport. Now it is reaching everyday buyers. What the…
Back to Catalogue
Keep exploring

Related Medical Devices reports in France

See all
Same topic, other categories

Related on obesity and fitness

See the topic